IP Library Granted Patent US 9,694,109
Granted Patent B1
US 9,694,109 · App. 14/988,841 · Granted Jul 4, 2017

Nanoparticle-containing placental constructs and methods of use

Inventor: Timothy R. Brahm (Germantown, TN)
Assignee: Brahm Holdings, LLC
A61L27/54A61K33/06A61K35/50A61L27/3604A61L27/40A61L2430/02A61L2430/34
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,694,109
App. No.
14/988,841
Granted
Jul 4, 2017
Kind
B1
Abstract

A placental construct is provided. The placental construct includes a therapeutically effective amount of human birth tissue material and a nanoparticle composition. Methods of treatment with the placental construct and a corresponding kit are also provided.

Claims (23)

1. A placental construct comprising:

a therapeutically effective amount of morselized human birth tissue material; and

a nanoparticle composition,

wherein the morselized human birth tissue composition includes one or more morselized components of the human placental organ selected from the group consisting of morselized placental globe, morselized umbilical cord, morselized chorionic membrane, and morselized amniotic membrane.

2. The placental construct of claim 1 , wherein the placental construct is formulated as a flowable, injectable semi-solid, single layer graft, or multi-layer graft.

3. The placental construct of claim 1 , wherein the nanoparticle composition includes one or more elemental ion nanoparticles selected from the group consisting of silver, gold, magnesium, copper, aluminum, titanium, indium, cobalt, nickel, silicon, zirconium, samarium, lanthanum, and zinc.

4. The placental construct of claim 1 , wherein the nanoparticle composition includes one or more elemental nanoparticles selected from the group consisting of silver, gold, magnesium, copper, aluminum, titanium, indium, cobalt, nickel, silicon, zirconium, samarium, lanthanum, and zinc.

5. The placental construct of claim 1 , wherein the nanoparticle composition may include one or more impurities selected from the group consisting of osmium, rhenium, rhodium, tin, platinum, lithium, sodium, silver, zinc, silicon, carbon, nitrogen, sulfur, iron, molybdenum, rubidium, copper, and potassium.

6. The placental construct of claim 1 , wherein the nanoparticle composition is dispersed within the human birth tissue material or applied to an inside surface of the resulting construct or applied to an outside surface of the resulting construct.

7. The placental construct of claim 1 , wherein the placental construct exhibits antimicrobial, antiviral, antifungal, angiogenic, neurogenic, collagenic, osteogenic properties, or any combination thereof.

8. The placental construct of claim 1 , further comprising amniotic fluid, amniotic fluid components, or a combination thereof.

9. A method of treating a skin condition or soft tissue defect of the skin comprising:

applying an effective amount of the construct of claim 1 to the skin condition or soft tissue defect of the skin.

10. The method of claim 9 , wherein the skin condition is selected from the group consisting of an ischemic wound, scar, traumatic wound, severe burn, and surgical wound.

11. The method of claim 9 , wherein the skin condition is selected from the group consisting of keratosis, melasma, pruritus, spider veins, lentigo, dermatitis, psoriasis, folliculitis, rosacea, impetigo, erysipelas, erythrasma, and eczema.

12. A method of treating a bone defect comprising

administering an effective amount of the placental construct of claim 1 to the bone defect.

13. The method of claim 12 , wherein the placental construct aids in bone regeneration.

14. A method of preventing or killing a pathological infection at a site on or within the body comprising

administering an effective amount of the placental construct of claim 1 to the site.

15. The method of claim 14 , wherein the nanoparticle composition comprises magnesium ions.

16. A kit comprising the placental construct of claim 1 .

17. The kit of claim 16 , further comprising instructions for use thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2017
From: BRAHM, TIMOTHY R.
To: BRAHM HOLDINGS, LLC
Reel/Frame 041047/0141 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 26, 2016
From: BIODLOGICS, LLC
To: BRAHM, TIMOTHY R.
Reel/Frame 039851/0802 →
Continuity (1)
Provisional Application 62100204 · Jan 6, 2015